[go: up one dir, main page]

CL2018002756A1 - Un proceso mejorado para la preparación de tartrato de butorfanol. - Google Patents

Un proceso mejorado para la preparación de tartrato de butorfanol.

Info

Publication number
CL2018002756A1
CL2018002756A1 CL2018002756A CL2018002756A CL2018002756A1 CL 2018002756 A1 CL2018002756 A1 CL 2018002756A1 CL 2018002756 A CL2018002756 A CL 2018002756A CL 2018002756 A CL2018002756 A CL 2018002756A CL 2018002756 A1 CL2018002756 A1 CL 2018002756A1
Authority
CL
Chile
Prior art keywords
preparation
improved process
butorphanol tartrate
butorphanol
tartrate
Prior art date
Application number
CL2018002756A
Other languages
English (en)
Inventor
Rahul Bhalerao
R Sridharan
Shivaji Sadashiv Kandre
Ganesh Suryakant Deore
Kishorkumar Shivajirao Kadam
Dharnidhar Mundhe
Original Assignee
Hikal Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hikal Ltd filed Critical Hikal Ltd
Publication of CL2018002756A1 publication Critical patent/CL2018002756A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18Aralkyl radicals
    • C07D217/20Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA PRESENTE INVENCIÓN SE REFIERE A UN PROCESO MEJORADO PARA LA PREPARACIÓN DE TARTRATO DE BUTORFANOL DE FÓRMULA (I).
CL2018002756A 2016-03-29 2018-09-27 Un proceso mejorado para la preparación de tartrato de butorfanol. CL2018002756A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN201621010777 2016-03-29

Publications (1)

Publication Number Publication Date
CL2018002756A1 true CL2018002756A1 (es) 2019-02-01

Family

ID=59963601

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2018002756A CL2018002756A1 (es) 2016-03-29 2018-09-27 Un proceso mejorado para la preparación de tartrato de butorfanol.

Country Status (12)

Country Link
US (1) US10544101B2 (es)
EP (1) EP3436425B1 (es)
JP (1) JP6980687B2 (es)
KR (1) KR20180129854A (es)
CN (1) CN109071414B (es)
AU (1) AU2017242268A1 (es)
CA (1) CA3019491A1 (es)
CL (1) CL2018002756A1 (es)
IL (1) IL261986B (es)
MX (1) MX2018011877A (es)
PH (1) PH12018550165A1 (es)
WO (1) WO2017168444A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109694348B (zh) * 2018-11-12 2022-07-05 江苏宝众宝达药业股份有限公司 一种右美沙芬中间体拆分母液中回收物料的消旋回收方法
CN112142668B (zh) * 2019-06-28 2022-06-21 苏州盛迪亚生物医药有限公司 一种酒石酸布托啡诺及其中间体的制备方法
CN112159356A (zh) * 2020-10-09 2021-01-01 赤峰艾克制药科技股份有限公司 一种氢溴酸右美沙芬中间体副产物的消旋回收方法
CN114685370A (zh) * 2020-12-25 2022-07-01 成都苑东生物制药股份有限公司 一种酒石酸布托啡诺晶型i及其制备方法和用途
CN116818928B (zh) * 2023-04-28 2024-04-19 杭州沐源生物医药科技有限公司 一种酒石酸布托啡诺注射液中杂质的分离检测方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH301667A (de) * 1949-07-29 1954-09-15 Hoffmann La Roche Verfahren zur Herstellung eines Morphinanabkömmlings.
US3775414A (en) * 1972-05-10 1973-11-27 Bristol Myers Co Process for the preparation of 14-hydroxymorphinan derivatives
US3980641A (en) * 1975-07-31 1976-09-14 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinans
US4052389A (en) * 1976-03-23 1977-10-04 Bristol-Myers Company Derivatives of 9,10-dihydroxy-1-(p-alkoxybenzyl)-perhydroisoquinoline oxazine-3-one
US4139534A (en) * 1977-02-17 1979-02-13 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
US4058531A (en) * 1976-03-23 1977-11-15 Bristol-Myers Company Process for the preparation of 14-hydroxymorphinan derivatives
JPS52136176A (en) * 1976-03-23 1977-11-14 Bristol Myers Co Method of improving 144hydroxymorphinan derivatives
CN102977021A (zh) * 2012-11-29 2013-03-20 威海迪之雅医药化工开发有限公司 一种氢溴酸右美沙芬的制备方法

Also Published As

Publication number Publication date
EP3436425A4 (en) 2019-09-04
JP2019511508A (ja) 2019-04-25
JP6980687B2 (ja) 2021-12-15
IL261986B (en) 2021-03-25
CN109071414A (zh) 2018-12-21
MX2018011877A (es) 2019-03-06
PH12018550165A1 (en) 2019-05-15
US20190112273A1 (en) 2019-04-18
CA3019491A1 (en) 2017-10-05
US10544101B2 (en) 2020-01-28
EP3436425A1 (en) 2019-02-06
EP3436425B1 (en) 2021-01-06
IL261986A (en) 2018-10-31
CN109071414B (zh) 2021-11-05
WO2017168444A1 (en) 2017-10-05
AU2017242268A1 (en) 2018-10-25
KR20180129854A (ko) 2018-12-05

Similar Documents

Publication Publication Date Title
AR132627A2 (es) Procesos para preparar compuestos intermediarios de utilidad para sintetizar compuestos de carbamoilpiridona policíclicos
NZ726356A (en) Processes for preparing antiviral compounds
PH12016502177A1 (en) Processes of preparing a jak1 inhibitor and new forms thereto
CL2018002756A1 (es) Un proceso mejorado para la preparación de tartrato de butorfanol.
BR112017019850A2 (pt) ?processo melhorado para a preparação de apremilast?
MX2021012440A (es) Farmacos precursores de oxabicicloheptanos.
CY1120763T1 (el) Νεες ενωσεις σουλφονυλαμινοβενζαμιδιου
MX369857B (es) Pirazinas moduladoras de receptor 6 acoplado a la proteina g (gpr6).
MX389099B (es) Proceso para la preparación de 3-cloro-2-vinilfenilsulfonatos.
IN2014MU01192A (es)
MX2019004024A (es) Metodo para preparar acetofenonas sustituidas con ciclopropilo.
MX382659B (es) Proceso para la preparación de derivados de tiazol.
IN2014MU00195A (es)
BR112018069255A2 (pt) processos para a preparação de ácidos heteroaril carboxílicos
MX2016015623A (es) Proceso para la preparacion de derivados dihidroisoxazol.
MX2016016398A (es) Preparacion de piperidin-4-carbotioamida.
IN2014MU00194A (es)
IN2014MU01196A (es)
MX2018006638A (es) Un proceso para la preparacion de acidos de 2-alquilo-4-trifluorom etil-3-alquilosulfonilbenzoico por la oxidacion de tioeter quimoselectivo.
BR112018007282A2 (pt) métodos para síntese total de resolvina e1
CL2016002925A1 (es) Procedimiento mejorado para preparar ácidos crotónicos sustituidos
MX2017011388A (es) Proceso para la preparacion de derivados de fenilisoxazolina sustituida.
MX2018007638A (es) Proceso mejorado para preparar crotonilaminopiridinas.
IN2014MU00858A (es)
IN2014MU01195A (es)